![Bilal Arif](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bilal Arif
Operationeel Directeur bij
KALVISTA PHARMA
Vermogen: 293 497 $ op 31-05-2026
Profiel
Bilal Arif currently works at KalVista Pharmaceuticals, Inc., as Chief Operating Officer from 2025.
Mr. Arif also formerly worked at Sarepta Therapeutics, Inc., as Chief Technical Operations Officer & Executive VP from 2022 to 2025, Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2017 to 2019, and Shire Plc, as Vice President-Technical Operations from 2015 to 2017.
Mr. Arif received his undergraduate degree from McGill University, graduate degree from Tufts University, Masters Business Admin degree from Instituto de Empresa SL, and undergraduate degree from Western New England University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-08-2025 | 16.424 ( 0,02% ) | 293 497 $ | 31-05-2026 |
Actieve functies van Bilal Arif
| Bedrijven | Functie | Begin |
|---|---|---|
| KALVISTA PHARMA | Operationeel Directeur | 06-10-2025 |
Eerdere bekende functies van Bilal Arif
| Bedrijven | Functie | Einde |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 12-08-2025 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2019 |
| SHIRE | Hoofd Techniek/Wetenschap/O&O | 01-03-2017 |
Opleiding van Bilal Arif
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University
 Western New England University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
 Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
